Thomas Colarusso

Thomas Colarusso has a diverse work experience spanning over several industries. Thomas is currently the CEO, President, and Co-Founder of Bio-AI Health, a leading AI for Digital Health in Precision Medicine company. At Bio-AI Health, they utilize a multi-Omic AI platform to enhance clinical biomarker development and assist biopharmaceutical partners in identifying appropriate patient signatures for clinical trials.

Before joining Bio-AI Health, Thomas held the position of VP, Pharma Business Development at HalioDx, a company specializing in immune response to cancer diagnostics. Prior to that, they served as the Executive Vice President of Business Development and Strategy at PathAI.

Thomas has also held various roles at Definiens, The Tissue Phenomics Company, including Vice President of Business Development and Strategy, Global Vice President of Business Development, and Vice President of Sales and Operations for North America.

Thomas'sprevious experience includes being the Director of Sales at GenoLogics Life Sciences Software Inc, Senior Sales Account Executive at Tripos Inc., and Regional Sales Account Manager at Nonlinear Dynamics, a Waters Company. Thomas also worked as a Sales Representative at Accelrys and a Technical Support Representative at Upstate Biotechnology.

Thomas began their career as a Research Technician and Lab Manager in the Department of Hematology & Oncology at Boston Medical Center.

Throughout their career, Thomas has demonstrated expertise in business development, strategy, sales, and management across various sectors, particularly within the fields of digital health and life sciences.

Thomas Colarusso attended the University of New Hampshire from 1992 to 1996, where they obtained a Bachelor of Science degree. Thomas'smajor was Microbiology, with a minor in Psychology.